Earnings

Thermo Fisher Scientific Raises FY2026 Adj EPS Guidance from $24.64-$25.12 to $24.93-$25.33 vs $24.86 Est; Raises FY2026 Sales Guidance from $47.300B-$48.100B to $47.400B-$48.100B vs $47.767B Est

Jul 23, 2026 · 09:33 AM ET· updated 2h ago

Thermo Fisher Scientific (NYSE:TMO) raises FY2026 Adj EPS guidance from $24.64-$25.12 to $24.93-$25.33 vs $24.86 analyst estimate. Raises FY2026 sales outlook from $47.300 billion-$48.100 billion to $47.400

Why It Matters

Thermo Fisher raised its profit forecast a little bit, saying it will make slightly more money than it thought before. This shows the company feels a bit more confident about its business, even though the new forecast is still close to what experts expected.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

TMO577.41

+50.95 (+9.68%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.